Literature DB >> 22359717

Early recognition and management of pulmonary arterial hypertension: a case for profiling.

Kalyan Kosuri1, Ghulam Saydain.   

Abstract

Entities:  

Year:  2012        PMID： 22359717      PMCID： PMC3282128          DOI： 10.5001/omj.2012.01

Source DB:  PubMed          Journal:  Oman Med J        ISSN： 1999-768X


× No keyword cloud information.
  12 in total

Review 1.  Update in pulmonary arterial hypertension 2007.

Authors:  Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2008-03-15       Impact factor: 21.405

2.  Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

Authors:  David B Badesch; Steven H Abman; Gerald Simonneau; Lewis J Rubin; Vallerie V McLaughlin
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

Review 3.  Diagnosis and assessment of pulmonary arterial hypertension.

Authors:  David B Badesch; Hunter C Champion; Miguel Angel Gomez Sanchez; Marius M Hoeper; James E Loyd; Alessandra Manes; Michael McGoon; Robert Naeije; Horst Olschewski; Ronald J Oudiz; Adam Torbicki
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

4.  A USA-based registry for pulmonary arterial hypertension: 1982-2006.

Authors:  T Thenappan; S J Shah; S Rich; M Gomberg-Maitland
Journal:  Eur Respir J       Date:  2007-09-05       Impact factor: 16.671

5.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension.

Authors:  Hilario Nunes; Marc Humbert; Olivier Sitbon; Jane H Morse; Zemin Deng; James A Knowles; Catherine Le Gall; Florence Parent; Gilles Garcia; Philippe Hervé; Robyn J Barst; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2003-02-25       Impact factor: 21.405

7.  Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

Authors:  David B Badesch; Gary E Raskob; C Greg Elliott; Abby M Krichman; Harrison W Farber; Adaani E Frost; Robyn J Barst; Raymond L Benza; Theodore G Liou; Michelle Turner; Scott Giles; Kathy Feldkircher; Dave P Miller; Michael D McGoon
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

8.  ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.

Authors:  Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094

Review 9.  Inhaled treprostinil and pulmonary arterial hypertension.

Authors:  Samuel T Nadler; Jeffrey D Edelman
Journal:  Vasc Health Risk Manag       Date:  2010-12-03

Review 10.  A meta-analysis of randomized controlled trials in pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Alessandra Manes; Luca Negro; Massimiliano Palazzini; Maria Letizia Bacchi-Reggiani; Angelo Branzi
Journal:  Eur Heart J       Date:  2009-01-20       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.